Medifast Posts $17.5 Million Q3 Loss, Guides December Quarter Revenue of $55M-$75M

Medifast Inc. (MED) on Monday reported a third-quarter loss of $17.5 million, or $1.57 per share, as the weight-loss company's revenue fell to $72 million. Adjusted for restructuring costs, the Baltimore-based company's loss was 19 cents per share. For the current quarter ending in December, Medifast forecast revenue of $55 million to $75 million. The company expects full-year results ranging from a loss of 70 cents per share to a loss of 45 cents per share, with revenue of $280 million to $300 million.